BBLG

Bone Biologics Corp (BBLG) is an innovative medical device company focused on enhancing bone regeneration technologies, particularly for spinal fusion procedures. Utilizing proprietary recombinant human protein formulations, Bone Biologics aims to improve surgical outcomes and expedite recovery for patients, addressing critical needs in orthopedics and spinal surgery. With its headquarters in Burlington, Massachusetts, the company is well-positioned to meet the increasing demand for effective bone healing solutions, solidifying its role as a prominent contributor to the evolving landscape of healthcare.